K-BPR: South Korea Urges Approval of Existing Active Substances
Enterprises handling Group B existing biocidal active substances are advised to submit dossiers in a timely manner since the corresponding deadline is approaching.
On March 10, 2023, South Korea’s Ministry of Environment (MoE) issued a notice to urge enterprises handling \’Group B existing biocidal active substances\’ to speed up dossier preparation and submission for approval under the Consumer Chemical Products and Biocides Safety Control Act (K-BPR). Under K-BPR, existing biocidal active substances are classified into four groups with the corresponding grace periods for approval depending on the product type. For Group B, the grace period for approval will expire on December 31, 2024.
Considering the fact that about 18 months will be taken for the administrative procedures of approval (including official review and technical evaluation after the dossier submission), by the notice, the MoE stipulates the corresponding deadlines for Group B active substances as below.
Pre-registration application submission deadline | 2023.3.31 |
Plan report submission deadline | 2023.6.30 |
Dossier submission deadline | 2023.6.30 |
The authority also emphasizes that, after the abovementioned deadline for dossier submission expires, the online application platform will be closed immediately and the applications for approval of Group B active substances will no longer be accepted.
[Read more at ChemLinked]
Contact Us
If you have any questions regarding the Consumer Chemical Products and Biocides Safety Control Act (K-BPR), please feel free to contact us.
Tel: +86-400-809-5809
Email: customer@reach24h.com
News Source: ChemLinked
REACH24H Consulting Group launched ChemLinked in 2012 as a leading service provider of comprehensive regulatory information and compliance solutions, meeting the growing demand for clear and concise regulatory advice and market intelligence in Asia, especially China.
Register for a membership to read the latest news limitlessly every day on ChemLinked.